| Patent application number | Description | Published |
|---|
| 20080241077 | BENZOYLGUANIDINE SALT AND HYDRATES THEREOF - 4-[4-(2-pyrrolylcarbonyl)-1-piperazinyl]-3-trifluoromethylbenzoylguanidine hydrochloride and its hydrates, processes for preparing this benzoylguanidine salt and its hydrates, pharmaceutical compositions containing this benzoylguanidine salt and its hydrates, and its use in treating diseases, particularly those in which inhibition of the cellular Na | 10-02-2008 |
| 20080293680 | Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II - The invention relates to a compound of the formula (I), wherein R | 11-27-2008 |
| 20080293944 | Piperazinyl Compounds - Disclosed are new dihydropteridinones of general formula (I) | 11-27-2008 |
| 20090042867 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The invention relates to substituted 1,2-ethylenediamines of general formula (I), | 02-12-2009 |
| 20090325940 | Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof - The present invention relates to substituted 1,2-ethylenediamines of general formula (I) | 12-31-2009 |
| 20100144681 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The invention relates to substituted 1,2-ethylenediamines of general formula (I), | 06-10-2010 |
| 20100168070 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The invention relates to substituted 1,2-ethylenediamines of general formula (I), | 07-01-2010 |
| 20100204160 | SUBSTITUTED 1,2-ETHYLENEDIAMINES, METHODS FOR PREPARING THEM AND USES THEREOF - The present invention relates to substituted 1,2-ethylenediamines of general formula (I) | 08-12-2010 |
| 20100249158 | SUBSTITUTED AMINO-QUINAZOLINONES, MEDICAMENTS COMPRISING SAID COMPOUND, THEIR USE AND THEIR METHOD OF MANUFACTURE - The present invention relates to substituted amino-quinazolinones of general formula (I) wherein the groups R | 09-30-2010 |
| 20100298278 | INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The invention relates to the substituted 1,2-ethylenediamines of general formula (I), | 11-25-2010 |
| 20110015193 | 1, 5-DIHYDRO-PYRAZOLO (3, 4-D) PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS PDE9A MUDULATORS FOR THE TREATMENT OF CNS DISORDERS - The invention relates to novel substituted pyrazolopyrimidines. Chemically, the compounds are characterised by general Formula (I): with R | 01-20-2011 |
| 20110082137 | NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS - The invention relates to novel 1,6-disubstituted pyrazolopyrimidinones of formula (I), | 04-07-2011 |
